Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

 PMID:26389676  

Isocitrate-to-SENP1 signaling amplifies insulin secretion and rescues dysfunctional β cells.

Mourad Ferdaoussi | Xiaoqing Dai | Mette V Jensen | Runsheng Wang | Brett S Peterson | Chao Huang | Olga Ilkayeva | Nancy Smith | Nathanael Miller | Catherine Hajmrle | Aliya F Spigelman | Robert C Wright | Gregory Plummer | Kunimasa Suzuki | James P Mackay | Martijn van de Bunt | Anna L Gloyn | Terence E Ryan | Lisa D Norquay | M Julia Brosnan | Jeff K Trimmer | Timothy P Rolph | Richard G Kibbey | Jocelyn E Manning Fox | William F Colmers | Orian S Shirihai | P Darrell Neufer | Edward T H Yeh | Christopher B Newgard | Patrick E MacDonald
The Journal of clinical investigation | 2015

Insulin secretion from β cells of the pancreatic islets of Langerhans controls metabolic homeostasis and is impaired in individuals with type 2 diabetes (T2D). Increases in blood glucose trigger insulin release by closing ATP-sensitive K+ channels, depolarizing β cells, and opening voltage-dependent Ca2+ channels to elicit insulin exocytosis. However, one or more additional pathway(s) amplify the secretory response, likely at the distal exocytotic site. The mitochondrial export of isocitrate and engagement with cytosolic isocitrate dehydrogenase (ICDc) may be one key pathway, but the mechanism linking this to insulin secretion and its role in T2D have not been defined. Here, we show that the ICDc-dependent generation of NADPH and subsequent glutathione (GSH) reduction contribute to the amplification of insulin exocytosis via sentrin/SUMO-specific protease-1 (SENP1). In human T2D and an in vitro model of human islet dysfunction, the glucose-dependent amplification of exocytosis was impaired and could be rescued by introduction of signaling intermediates from this pathway. Moreover, islet-specific Senp1 deletion in mice caused impaired glucose tolerance by reducing the amplification of insulin exocytosis. Together, our results identify a pathway that links glucose metabolism to the amplification of insulin secretion and demonstrate that restoration of this axis rescues β cell function in T2D.

Pubmed ID: 26389676

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: Wellcome Trust, United Kingdom
    Id: 095101/Z/10/Z
  • Agency: NHLBI NIH HHS, United States
    Id: T32 HL007969
  • Agency: NIDDK NIH HHS, United States
    Id: DK42538
  • Agency: Canadian Institutes of Health Research, Canada
    Id: MOP244739
  • Agency: NIGMS NIH HHS, United States
    Id: T32 GM007105
  • Agency: Wellcome Trust, United Kingdom
    Id: 095101

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.